ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.1413C>G (p.Tyr471Ter)

dbSNP: rs78218617
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001225302 SCV001397585 pathogenic Glanzmann thrombasthenia 2020-09-06 reviewed by expert panel curation The ITGA2B nonsense variant NM_000419.4:c.1413C>G (p.Tyr471Ter) introduces a premature termination codon and the resulting mRNA product is predicted to undergo nonsense mediated decay, leading to loss of normal protein function. This variant has been observed in a proband with a phenotype specific for Glanzmann's thrombasthenia (GT) who also harbors a second ITGA2B variant (c.1882C>T, p.Arg628Ter) previously classified by the VCEP as pathogenic. Furthermore, this variant has been reported in low frequencies in population databases (<1/10,000 alleles in gnomAD). In summary, this variant meets criteria to be classified as pathogenic for GT. GT-specific criteria applied: PVS1, PM2_Supporting, PM3_supporting, and PP4_strong.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.